Table 1.
Author | Year | Article type | Number of patients | Treatment | Outcome | Comments |
---|---|---|---|---|---|---|
Bal et al. [9] | 2013 | Case report | 1 (anal, primary) | Standard | <20% 5-year survival | |
| ||||||
Richardson et al. [14] | 2012 | Case report | 1 (brain, secondary) | Chemo and surgery provide best outlook | ||
| ||||||
Lee et al. [12] | 2011 | Case report/lit. review | 1 | Standard | Prognosis of BCMM does not depend on the degree of balloon cell change, tumor size, nuclear atypia, or mitotic activity | |
| ||||||
Kao et al. [11] | 1992 | Cohort study | 34 | Standard | 57.5% died at 2–12 years from metastasis. 18.2% developed local recurrences: 15.2% alive with metastatic tumours 21.2% alive without evidence of disease | Prognosis of BCMM usually correlates with the tumour thickness |
| ||||||
Peters and Su [15] | 1985 | Case report/lit. review | 1 | Standard | Many balloon cell melanomas show only mild cellular atypia and minimal mitotic figures although the tumour has a malignant course. | |
| ||||||
Fievez [16] | 1984 | Lit. review | Unknown | Unknown | 6.3-year median survival | |
| ||||||
Jakobiec et al. [13] | 1979 | Case series | 2 (ciliary body) | Unknown | Abundant number of balloon cells probably comparatively dormant and benign tumours |